Gainey mckenna & egleston announces a class action lawsuit has been filed against nrx pharmaceuticals, inc. (nrxp; nrxpw)

New york, new york--(newsfile corp. - january 19, 2022) - gainey mckenna & egleston announces that a class action lawsuit has been filed against nrx pharmaceuticals, inc. ("nrx") (nasdaq: nrxp) (nasdaq: nrxpw) in the united states district court for the district of delaware on behalf of investors who purchased nrx's common stock between june 1, 2021 and november 4, 2021, both dates inclusive (the "class period").the complaint alleges that defendants made false and/or misleading statements...
NRXP Ratings Summary
NRXP Quant Ranking